Catarina Paone
Acute Care · Albany, NYNPI 1508851098
Payments from drug & device makers
Across 84 payments — averaging $14.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$319
- Merck$215
- Kiniksa Pharmaceuticals International, PLC$168
- AstraZeneca$138
- Kiniksa Pharmaceuticals, Ltd.$126
- Medtronic$77
- plus $195 from 6 others
What the payments were for
- Food & beverage$1,13892%
- Education$1008%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 40 | $319 |
| Merck | 12 | $215 |
| Kiniksa Pharmaceuticals International, PLC | 7 | $168 |
| AstraZeneca | 3 | $138 |
| Kiniksa Pharmaceuticals, Ltd. | 7 | $126 |
| Medtronic | 3 | $77 |
| Scpharmaceuticals Inc. | 3 | $50 |
| Boehringer Ingelheim | 3 | $49 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $36 |
| Johnson & Johnson | 2 | $33 |
| Cvrx, Inc. | 1 | $13 |
| Novo Nordisk | 1 | $13 |
How this compares
$1,238 in reported general payments places this provider in the 80th percentile of 980 acute care providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 40 | $29,375 |
| Amiodarone Hcl | 15 | $845 |
| Bumetanide | 43 | $466 |
| Losartan Potassium | 25 | $290 |
| Metoprolol Succinate | 52 | $239 |
| Carvedilol | 29 | $234 |
| Nifedipine ErNifedipine | 14 | $188 |
| Hydralazine Hcl | 12 | $165 |
| Torsemide | 16 | $141 |
| Atorvastatin Calcium | 17 | $128 |
| Metoprolol Tartrate | 23 | $124 |
| Irbesartan | 11 | $88 |
| Rosuvastatin Calcium | 11 | $77 |
| Atenolol | 14 | $32 |
| Furosemide | 29 | $30 |
Paid to pharmacies, not to this prescriber.
Other acute care in Albany
- Darshaney SankharAlbany$5K
- Dale WebsterAlbany$4K
- Daniel VerinaNew York$464K
- Michele BiscossiSaratoga Springs$64K
- Heidi YipCanandaigua$29K
- Katie WorthingtonNew York$25K
- Loveth AdenugaNew York$20K
- Katherine DukeNew York$18K
- Ann HarrisBrooklyn$14K
- Marcel RozarioMedina$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.